Allakos Cash from Financing (Quarterly) Insights

Allakos Inc (ALLK)

1.45 0.00 (0.00%) USD | NASDAQ | May 17, 16:00

1.45 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	0.132M
December 31, 2023	0.00
September 30, 2023	1.07M
June 30, 2023	0.00
March 31, 2023	1.458M
December 31, 2022	0.19M
September 30, 2022	141.28M
June 30, 2022	0.066M
March 31, 2022	0.347M
December 31, 2021	0.864M
September 30, 2021	3.813M
June 30, 2021	0.80M
March 31, 2021	4.783M
December 31, 2020	274.81M
September 30, 2020	1.526M

Date	Value
June 30, 2020	1.708M
March 31, 2020	0.789M
December 31, 2019	0.008M
September 30, 2019	380.05M
June 30, 2019	0.138M
March 31, 2019	0.963M
December 31, 2018	0.004M
September 30, 2018	140.01M
June 30, 2018	-0.818M
March 31, 2018	-0.447M
December 31, 2017	87.10M
September 30, 2017	7.448M
June 30, 2017	0.072M
March 31, 2017	0.003M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

Minimum

Jun 2023

380.05M

Maximum

Sep 2019

40.69M

Average

0.832M

Median

Cash from Financing (Quarterly) Benchmarks

Tonix Pharmaceuticals Holding Corp	40.71M
RAPT Therapeutics Inc	9.036M
NovaBay Pharmaceuticals Inc	-0.597M
Palatin Technologies Inc	4.974M
iBio Inc	4.005M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-32.54M
Cash from Investing (Quarterly)	9.029M
Free Cash Flow	-119.21M
Free Cash Flow Per Share (Quarterly)	-0.3697
Free Cash Flow Yield	-94.13%